Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | CES2 | O00748 | 3/20 | 0.41 |
| ▸ | CES1 | P23141 | 3/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22283347 | 1.00 | TSHR (0.53) | TSHRTHRBCES2CES1EPHX2 | |
| SCHEMBL22283393 | 1.00 | TSHR (0.53) | TSHRTHRBCES2CES1EPHX2 | |
| SCHEMBL22283422 | 1.00 | TSHR (0.53) | TSHRTHRBCES2CES1EPHX2 | |
| SCHEMBL17024459 | 1.00 | TSHR (0.53) | TSHRTHRBCES2CES1EPHX2 | |
| SCHEMBL10594320 | 0.97 | TSHR (0.50) | TSHRTHRBCES2CES1EPHX2 | |
| SCHEMBL15520741 | 0.97 | TSHR (0.47) | TSHRTHRBCES2CES1EPHX2 | |
| SCHEMBL9256406 | 0.86 | TSHR (0.43) | TSHRTHRBCES2CES1EPHX2 | |
| SCHEMBL10605582 | 0.81 | TSHR (0.47) | TSHRTHRBCES2CES1EPHX2 | |
| SCHEMBL8592680 | 0.81 | TSHR (0.47) | TSHRTHRBCES2CES1EPHX2 | |
| SCHEMBL21372501 | 0.81 | TSHR (0.47) | TSHRTHRBCES2CES1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3689891-B1 | COBALT COMPLEX, PRODUCTION METHOD THEREFOR, AND CATALYST FOR HYDROSILYLATION REACTION | UNIV KYUSHU NAT UNIV CORP (JP) | 2023-03-01 | — | — | EP | disclosed |
| US-20200247957-A1 | COBALT COMPLEX, PRODUCTION METHOD THEREFOR, AND CATALYST FOR HYDROSILYLATION REACTION | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2020-08-06 | — | — | US | disclosed |
| EP-3689891-A1 | COBALT COMPLEX, PRODUCTION METHOD THEREFOR, AND CATALYST FOR HYDROSILYLATION REACTION | Kyushu University, National University Corporation (JP) | 2020-08-05 | — | — | EP | disclosed |
| CN-111132990-A | Cobalt complex, process for producing the same, and catalyst for hydrosilylation | 国立大学法人九州大学 | 2020-05-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200247957-A1 | COBALT COMPLEX, PRODUCTION METHOD THEREFOR, AND CATALYST FOR HYDROSILYLATION REACTION | OR51E2, WEE2, SLC39A11 | TSHR 2694/4885THRB 3883/4885CES2 824/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.